Parallel Advisors’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02K Buy
282
+132
+88% +$1.02K ﹤0.01% 3401
2026
Q1
$956 Hold
150
﹤0.01% 3548
2025
Q4
$1.06K Sell
150
-33
-18% -$199 ﹤0.01% 3283
2025
Q3
$1.01K Buy
183
+33
+22% +$162 ﹤0.01% 3217
2025
Q2
$776 Hold
150
﹤0.01% 3247
2025
Q1
$999 Sell
150
-12
-7% -$91 ﹤0.01% 3129
2024
Q4
$1.19K Sell
162
-18
-10% -$129 ﹤0.01% 3078
2024
Q3
$1.26K Hold
180
﹤0.01% 2987
2024
Q2
$884 Buy
180
+64
+55% +$386 ﹤0.01% 2991
2024
Q1
$716 Hold
116
﹤0.01% 2993
2023
Q4
$908 Sell
116
-39
-25% -$251 ﹤0.01% 2955
2023
Q3
$1.06K Sell
155
-380
-71% -$3.08K ﹤0.01% 2964
2023
Q2
$4.88K Buy
535
+65
+14% +$540 ﹤0.01% 2442
2023
Q1
$3.49K Buy
470
+440
+1,467% +$2.44K ﹤0.01% 2552
2022
Q4
$148 Buy
+30
New +$186 ﹤0.01% 3227

Other funds holding LFST

Parallel Advisors's LFST Position: Q2 2026 in Review

Parallel Advisors increased its Lifestance Health (LFST) stake by 88% in Q2 2026, buying an estimated $1.02K and bringing the position to 282 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3401.

Parallel Advisors first reported a position in LFST in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.88K in Q2 2023. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Parallel Advisors held 282 shares of Lifestance Health worth $3.02K as of Q2 2026.
  • Parallel Advisors bought 132 Lifestance Health shares in Q2 2026, an estimated $1.02K.
  • Lifestance Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3401 holding.
  • Parallel Advisors first reported a position in Lifestance Health in Q4 2022 and has held it in 15 quarters since.
  • Parallel Advisors's Lifestance Health position peaked at $4.88K in Q2 2023.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.